Christopher M. Walsh

Internal Medicine
2800 S Shirlington Rd Ste 600
Arlington, VA 22206

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Growth hormone receptor antagonism improves tumoral chemo-immunotherapy response in a mouse model of lung cancer.

Growth hormone receptor antagonism improves tumoral chemo-immunotherapy response in a mouse model of lung cancer.

Journal: Translational oncology
Published: February 23, 2026

Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer.

Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences
Published: November 13, 2025

GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells.

GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells.

Journal: Endocrinology
Published: October 16, 2025

Lymphatic pumping technique in mice alters blood parameters and metastatic melanoma in an age-dependent manner.

Lymphatic pumping technique in mice alters blood parameters and metastatic melanoma in an age-dependent manner.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: October 03, 2025

Sex-Specific transcriptomic changes in adipose tissue following adult-onset disruption of growth hormone receptor.

Sex-Specific transcriptomic changes in adipose tissue following adult-onset disruption of growth hormone receptor.

Journal: Pituitary
Published: June 16, 2025

Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer.

Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer.

Journal: International journal of molecular sciences
Published: May 10, 2024

Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.

Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.

Journal: Cancers
Published: July 30, 2019
Showing 1-7 of 7

Last Updated: 09/26/2026